Global Metabotropic Glutamate Antagonists Supply, Demand and Key Producers, 2023-2029

Global Metabotropic Glutamate Antagonists Supply, Demand and Key Producers, 2023-2029

The global Metabotropic Glutamate Antagonists market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Metabotropic Glutamate Antagonists act by inhibiting the activity of glutamate receptors in the brain. These receptors are broadly divided into two major subtypes: N-methyl-D-aspartate (NMDA) and 3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.

This report studies the global Metabotropic Glutamate Antagonists production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Metabotropic Glutamate Antagonists, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Metabotropic Glutamate Antagonists that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Metabotropic Glutamate Antagonists total production and demand, 2018-2029, (K Units)

Global Metabotropic Glutamate Antagonists total production value, 2018-2029, (USD Million)

Global Metabotropic Glutamate Antagonists production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Metabotropic Glutamate Antagonists consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Metabotropic Glutamate Antagonists domestic production, consumption, key domestic manufacturers and share

Global Metabotropic Glutamate Antagonists production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Metabotropic Glutamate Antagonists production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Metabotropic Glutamate Antagonists production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Metabotropic Glutamate Antagonists market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Artemis Neuroscience, VistaGen Therapeutics, Rottapharm Madaus, Amorsa Therapeutics, Newron Pharmaceuticals, Purdue Biopharma, Relmada Therapeutics, BioCrea GmbH and Cerecor Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Metabotropic Glutamate Antagonists market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Metabotropic Glutamate Antagonists Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Metabotropic Glutamate Antagonists Market, Segmentation by Type
Ionic
Non Ionic

Global Metabotropic Glutamate Antagonists Market, Segmentation by Application
Hospitals And Clinics
Research Institutes
Others

Companies Profiled:
Artemis Neuroscience
VistaGen Therapeutics
Rottapharm Madaus
Amorsa Therapeutics
Newron Pharmaceuticals
Purdue Biopharma
Relmada Therapeutics
BioCrea GmbH
Cerecor Inc.
NeurOp Inc.
UCB SA
Novartis AG
Luc Therapeutics Inc.
Evotec AG

Key Questions Answered

1. How big is the global Metabotropic Glutamate Antagonists market?

2. What is the demand of the global Metabotropic Glutamate Antagonists market?

3. What is the year over year growth of the global Metabotropic Glutamate Antagonists market?

4. What is the production and production value of the global Metabotropic Glutamate Antagonists market?

5. Who are the key producers in the global Metabotropic Glutamate Antagonists market?

6. What are the growth factors driving the market demand?